Clinacox 0.5% 5 g Drug Premix is a Health Canada–registered veterinary drug (DIN 02246048) held by Elanco Canada Limited, containing Diclazuril. Health Canada lists its status as Dormant (status date 30 Jul 2026). Nexara Health has matched 11 registrations of Diclazuril across 5 other regulated markets.
Health Canada registration
| DIN | 02246048 |
|---|---|
| Brand name | Clinacox 0.5% |
| Active ingredient | Diclazuril |
| Strength | 5 g |
| Dosage form | Drug Premix |
| Route | Oral |
| Company | Elanco Canada Limited |
| Status | Dormant — 30 Jul 2026 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Status and company history
Changes Health Canada has recorded for this DIN, as observed by Nexara Health's weekly DPD comparison.
| Date | Field | From | To |
|---|---|---|---|
| 2026-09-03 | Status | Marketed | Dormant |
| 2026-09-03 | Status | Marketed | Dormant |
Diclazuril registered in other markets
11 registrations of the same molecule in 5 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Dycoxan | Chanelle Pharmaceuticals Manufacturing Limited | 2,5 mg/ml | oral suspension | Decentral procedure | Laegemiddelstyrelsen |
| Iceland | Vecoxan | Icepharma - óskráð | 2,5 mg/ml | mixtúra | 0 | Lyfjastofnun lyfjaverdskra |
| Malaysia | Pf Diclazuril Premix 0.5% W/W Powder | Panfast Marketing (m) Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Vetricox 5mg/mL Solution | Range Pharma Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Poland | Bimacox | Bimeda Animal Health Ltd. | 2,5 mg/ml | Zawiesina doustna | Bezterminowe | URPL RPL |
| Poland | Cocciril | Huvepharma NV | 2,5 mg/ml | Zawiesina doustna | Bezterminowe | URPL RPL |
| Poland | Dycoxan | Chanelle Pharmaceuticals Manufacturing Ltd. | 2,5 mg/ml | Zawiesina doustna | Bezterminowe | URPL RPL |
| United States | Diclazuril | Changzhou Yabang-Qh Pharmachem Co., Ltd | Powder | FDA NDC | ||
| United States | Diclazuril | Alivira Animal Health Limited | Powder | FDA NDC | ||
| United States | Diclazuril | Zhejiang Guobang Pharmaceutical Co., Ltd. | Powder | FDA NDC | ||
| United States | Diclazuril | Kalchem International Inc | Powder | FDA NDC |
See every manufacturer of Diclazuril worldwide →
Regulator price references for Diclazuril
Published list or reimbursement prices for Diclazuril presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Iceland | Vecoxan | 2.5mg/1ml | glas | 34,000.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Clinacox 0.5% (DIN 02246048) marketed in Canada?
No. Health Canada lists DIN 02246048 as Dormant as of 30 Jul 2026.
Who holds the Canadian licence for this product?
Elanco Canada Limited is the company of record in the Health Canada Drug Product Database.
Is Diclazuril registered outside Canada?
Yes — Nexara Health has matched 11 registrations in 5 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02246048, status date 2026-07-30; national medicine registries: FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02246048, status date 2026-07-30; national medicine registries: FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra.
Health Canada Drug Product Database (DPD), DIN 02246048, status date 2026-07-30; national medicine registries: FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.